1 / 9

Management of Chronic Heart Failure SIGN 95

Management of Chronic Heart Failure SIGN 95. Chronic Heart Failure (CHF). Diagnosis Treatment drugs after ACEI/BB devices models of care. BNP (or NT pro-BNP) and/or ECG. Diagnostic algorithm for patients with suspected CHF. Symptoms or signs suggestive of CHF. Clinical examination

idalee
Download Presentation

Management of Chronic Heart Failure SIGN 95

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Management of Chronic Heart Failure SIGN 95

  2. Chronic Heart Failure (CHF) • Diagnosis • Treatment drugs after ACEI/BB devices models of care

  3. BNP (or NT pro-BNP) and/or ECG Diagnostic algorithm for patients with suspected CHF Symptoms or signs suggestive of CHF Clinical examination (full blood count, fasting blood glucose, serum urea and electrolytes, urinalysis, thyroid function and chest X-ray)

  4. BNP (or NT pro-BNP) and/or ECG Low BNP (or NT pro-BNP) and normal ECG Raised BNP (or NT pro-BNP) or abnormal ECG CHF Excluded CHF Possible Consider alternative cause for symptoms Refer for echocardiography ECG (if not already done, to determine cause of CHF)

  5. Which drugs to prescribe by NYHA class Class Prescribe ______________________________________________________________________________ NYHA I (no limitation of physical activity) ACE inhibitor beta blocker NYHA II-III (slight limitation) ACE inhibitor beta blocker candesartan (requires specialist) NYHA III-IV (marked limitation or inability) ACE inhibitor beta blocker spironolactone (requires specialist)

  6. Other New Drugs ACEI intolerant ARB African-American Hydralazine/ Isosorbide dinitrate

  7. Cardiac Resynchronisation Therapy LVSD (LVEF <35%) NYHA III-IV CRT QRS >120m/s Above plus ICD implantation criteria CRT-D

  8. Models of Care • Comprehensive discharge planning • Multidisciplinary follow up Nurses Home VisitsTelephone Pharmacist

  9. Summary BNP/ECG prior to echo Echo service capacity ACEI • Blockers Spironolactone/Candesartan CRT CRT-D Nurse Follow Up

More Related